Rare
lephants
Screener
Toggle theme
VASO CORPORATION
VASO
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2017
FY2016
FY2015
FY2014
FY2012
FY2011
Total Cash from Operations:
$2.6M
Line Item
Value
% of Total
Capital Expenditures
$278.0K
10.7%
Stock Repurchases
$82.0K
3.2%
Other
$1.1M
41.1%
Net Cash Flow
$1.2M
45.0%
Download CSV
